Trial Profile

Proof-of-concept phase I trial of ACH 3422 in patients with chronic hepatitis C

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 16 Mar 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ACH 3422 (Primary)
Indications Hepatitis C
Focus Adverse reactions; Proof of concept

Most Recent Events

05 Mar 2015 Results are anticipated during the second quarter of 2015, according to an Achillion Pharmaceuticals media release.
05 Mar 2015 Planned initiation date changed from 1 Jul 2014 to 1 Mar 2015, according to an Achillion Pharmaceuticals media release.
14 Feb 2014 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com